Drug Type Small molecule drug |
Synonyms DP-R213 |
Target |
Action modulators |
Mechanism ERα modulators(Estrogen receptor alpha modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (29 Sep 2017), |
Regulation- |
Molecular FormulaC28H28ClNO4S |
InChIKeyBKXVVCILCIUCLG-UHFFFAOYSA-N |
CAS Registry82640-04-8 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Osteoporosis | South Korea | 29 Sep 2017 |